A review of regulatory filings reveals that Elizabeth Roaldsen, Senior Vice President at Paychex Inc., reported the disposition of company common stock on May 13, 2026. According to the SEC filing, Roaldsen sold 459 shares of Paychex common stock, each purchased at a price point of $90.0 per share. This transaction totaled $41,310 in value.
This reported sale took place within a period when the company's shares were trading close to their 52-week low, which stands at $85.45. At the time of reporting, the stock was priced at $91.54, reflecting a decline of 40% over the preceding year.
Following this specific transaction, the filing indicates that Roaldsen continues to directly hold an ownership stake comprising 9,335 shares of Paychex common stock. Despite the observable recent price softness in the equity, independent analysis provided by InvestingPro suggests that the underlying value of the stock may be undervalued. This assessment is supported by the company's history of maintaining a dividend payment streak spanning 39 years and its current yield offering of 5.36%.
The regulatory disclosure also detailed Roaldsen's derivative holdings related to the company's equity. These holdings include several distinct tranches of stock options, which grant the holder the right to acquire common stock at specific exercise prices on future dates. The details of these options are as follows:
- 12,164 shares with an exercise price of $120.86, exercisable starting July 15, 2024
- 2,119 shares at a lower exercise price of $117.98, available from October 15, 2024
- 14,291 shares with an exercise price of $121.63, exercisable beginning July 15, 2025
- 11,518 shares at the highest listed exercise price of $140.68, available from July 15, 2026
In separate corporate news, Paychex Inc. recently reported financial results that included a commendable 20% growth in revenue and a 14% increase in earnings per share (EPS). Both of these figures surpassed the consensus estimates provided by market analysts.
The reaction to this strong performance from various institutional investors was varied:
- Jefferies lowered its price target for Paychex stock, adjusting it down from $110 to $105. This reduction was attributed by the firm to valuation concerns, although Jefferies maintained a